Disconnecting multicellular networks in brain tumours

V Venkataramani, M Schneider, FA Giordano… - Nature Reviews …, 2022 - nature.com
Cancer cells can organize and communicate in functional networks. Similarly to other
networks in biology and sociology, these can be highly relevant for growth and resilience. In …

[HTML][HTML] Microtubule targeting agents in disease: classic drugs, novel roles

L Wordeman, JJ Vicente - Cancers, 2021 - mdpi.com
Simple Summary Microtubules (MTs) are highly conserved proteins present in all eukaryotic
organisms. They form the cell cytoskeleton, and its function is essential for a large number of …

[HTML][HTML] Brain tumor networks in diffuse glioma

Y Yang, MC Schubert, T Kuner, W Wick, F Winkler… - …, 2022 - Elsevier
Diffuse gliomas are primary brain tumors associated with a poor prognosis. Cellular and
molecular mechanisms driving the invasive growth patterns and therapeutic resistance are …

[HTML][HTML] A clinically applicable connectivity signature for glioblastoma includes the tumor network driver CHI3L1

L Hai, DC Hoffmann, RJ Wagener, DD Azorin… - Nature …, 2024 - nature.com
Tumor microtubes (TMs) connect glioma cells to a network with considerable relevance for
tumor progression and therapy resistance. However, the determination of TM …

[HTML][HTML] The cytoskeleton effectors rho-kinase (ROCK) and mammalian diaphanous-related (mDia) formin have dynamic roles in tumor microtube formation in invasive …

KN Becker, KM Pettee, A Sugrue, KA Reinard… - Cells, 2022 - mdpi.com
Glioblastoma (GBM) is a progressive and lethal brain cancer. Malignant control of actin and
microtubule cytoskeletal mechanics facilitates two major GBM therapeutic resistance …

Lucanthone, a potential PPT1 inhibitor, perturbs stemness, reduces tumor microtube formation, and slows the growth of temozolomide-resistant gliomas in vivo

DP Radin, S Shifman, IR Outhwaite, A Sharma… - … of Pharmacology and …, 2024 - ASPET
Glioblastoma (GBM) is the most frequently diagnosed primary central nervous system tumor
in adults. Despite the standard of care therapy, which includes surgical resection …

[HTML][HTML] GPER agonist G-1 disrupts tubulin dynamics and potentiates temozolomide to impair glioblastoma cell proliferation

A Hirtz, N Lebourdais, F Rech, Y Bailly, A Vaginay… - Cells, 2021 - mdpi.com
Glioblastoma (GBM) is the most common brain tumor in adults, which is very aggressive,
with a very poor prognosis that affects men twice as much as women, suggesting that female …

[PDF][PDF] A clinically applicable connectivity signature for glioblastoma includes the tumor network

DD Azorin, D Hausmann, R Xie… - Nature …, 2024 - opus.bibliothek.uni-augsburg.de
Results Development of a connectivity signature for GB We first explored the transcriptomic
landscape of TM-connected human patient-derived glioblastoma cells (PDGCs). Three …

[HTML][HTML] Synergistic Effects of A Combined Treatment of Glioblastoma U251 Cells with An Anti-miR-10b-5p Molecule and An AntiCancer Agent Based on 1-(3′, 4′, 5 …

M Zurlo, R Romagnoli, P Oliva, J Gasparello… - International Journal of …, 2022 - mdpi.com
(1) Background: In the development of new and more effective anticancer approaches,
combined treatments appear of great interest. Combination therapy could be of importance …

Novel 4-Aryl-4H-chromene derivative displayed excellent in vivo anti-glioblastoma efficacy as the microtubule-targeting agent

H Yang, D Zhang, Z Yuan, H Qiao, Z Xia, F Cao… - European Journal of …, 2024 - Elsevier
In this study, a series of novel 4-Aryl-4H-chromene derivatives (D1-D31) were designed and
synthesized by integrating quinoline heterocycle to crolibulin template molecule based on …